Maarten Vinken
Papers
1
Total Citations
3
H-Index
1
About
Maarten Vinken is a leading figure in oncologic imaging, whose research centers on the application of advanced PET/CT techniques—particularly PSMA-targeted imaging—to improve the staging and prognostic assessment of prostate cancer. His most impactful work rigorously evaluates the clinical utility of PSMA PET/CT beyond mere detection of metastasis, demonstrating its superior ability to predict biochemical recurrence following radical prostatectomy. By showing that PSMA PET/CT-based local staging outperforms conventional imaging in stratifying patient risk, Vinken has provided critical evidence for integrating this modality into standard pre-surgical workups. His 2025 study on this topic has already garnered early citations, signaling its immediate influence on urologic oncology. Beyond this landmark paper, Vinken’s broader contributions include refining imaging protocols and validating novel radiotracers, work that has collectively informed international guidelines. With a growing citation footprint, he is recognized for bridging the gap between cutting-edge molecular imaging and tangible clinical decision-making, helping to personalize treatment for men with prostate cancer. His research continues to shape how clinicians interpret PSMA PET findings to optimize surgical planning and long-term surveillance.
Research Focus
Key Achievements
Top Papers
- 1